| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +247 | 50% | $0.9620 | +$238 |
| Sells | 2 | -251 | 50% | $0.9619 | -$241 |
| Net | -1 | -4 | -0.8% | -$3.82 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 10%+ Owner | $697,550 | 02 Jan 2026 | ||
| Brian Achenbach | SVP, Fin. & Corp. Controller | $74,738 | 08 Dec 2021 | ||
| LINDSAY A. ROSENWALD MD | Director | $31,255 | 05 Jul 2023 | ||
| Michael S. Weiss | Director | $25,633 | 05 Jul 2023 | ||
| MICHAEL J. ZELEFSKY | Director | $9,796 | 05 Jul 2023 | ||
| Peter J. Carney | Interim Chief Accounting Officer, Exhibit 24 - Power of Attorney | $2,061 | 11 Dec 2023 | ||
| M.D. Manuel Litchman | President, CEO and Interim CFO, Director | $2,026 | 24 Apr 2025 | ||
| Adam Chill | Director | $358 | -$4 | -1.1% | 30 Dec 2025 |
| David Jin | Director | $275 | +$238 | +643% | 30 Dec 2025 |
| Neil Herskowitz | Director | $139 | -$238 | -63% | 30 Dec 2025 |
| Eliot M. Lurier | Interim CFO | 18 Apr 2022 | |||
| James B. Murphy | Interim CFO | 19 Jan 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|